Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Urol Oncol. 2023 Jul 7;41(9):391.e5–391.e11. doi: 10.1016/j.urolonc.2023.06.010

Table 2.

Comparison of peri-operative features between pT1a and pT3a SRMs

Characteristic pT1a*
N = 1,671
pT3a*
N = 166
p-value**

Mean age at nephrectomy 59 ± 11 62 ± 12 < 0.001

Male gender 1,079 (58.7%) 126 (76%) 0.003

BMI 30 ± 6.1 30.7 ± 6.2 0.2

Charlson comorbidity Index 0.82 ± 1.29 0.98 ± 1.4 0.1

Previously on active surveillance 106 (6.3%) 14 (8.4%) 0.3

R.E.N.A.L nephrometry score 6.83 ± 1.7 7.82 ± 1.9 < 0.001

Adverse radiologic features 259 (15.5%) 82 (49%) < 0.001

Underwent radical nephrectomy 64 (3.8%) 35 (20%) < 0.001

Surgery done via minimally invasive approach 703 (42.1%) 68 (41%) 0.8

Tumor size (max diameter) on pathology 2.5 ± 0.9 3.0 ± 0.9 < 0.001

Positive surgical margin 69 (4.1%) 16 (9.6%) < 0.001

Tumor histology predominantly ccRCC 1,039 (62.2%) 110 (66%) 0.3

Nuclear grade < 0.001
G1/2 786 (47%) 41 (25%)
G3/4 568 (34%) 104 (63%)
NA 317 (19%) 21 (13%)
*

Mean ± SD; n (%)

**

Student’s T-test; Pearson’s Chi-squared test